Drugs tested in clinical trials are suspected of being
more effective than currently available medications.
Patients who participate in clinical trials are often the
first to reap the benefits. Should the drug not turn out
to be as good as suspected, the clinical trial will be
stopped and all patients taking the study drug put on
other medications.
Here’s what you need to know if you have the option of participating in a phase 3 trial of a new medication. By Holly Strawbridge If you were offered a medication that might lower your risk of heart attack further than any drug that is currently available, would you be interested? What if your doctor […]
To continue reading this article or issue you must be a paid subscriber. Sign in
